Contact Us

MEETING NEWS

Suppliers and Local SMEs Honoured at Sands Supplier Excellence Awards and Sands Procurement Academy Graduation

Nov 28, 2024

MACAU,Nov. 27,2024-- Sands Chinarecognised some of its most outstanding suppliers at the Sands Supplier Excellence Awards Tuesday at The Parisian® Macao. The awards were part of a joint event wher

Appian Announces 2024 APJ Partner Award Winners

Nov 28, 2024

Recognising WNS-Vuram,Deloitte,Cognizant,KPMG,Accenture,and Via Appia for delivering process excellence

SHEIN is launching the ULTIMATE Giftorium experience just in time for the Festive Season

Nov 28, 2024

MELBOURNE,Australia,Nov. 28,2024-- Global fashion giant SHEIN will bring the ultimate Giftorium experience to life,right in time for the festive season.

Celebrate the Season of Gratitude with baleaf: Stay Warm and Stylish This Winter with Our Best-Selling Fleece-Lined Yoga Pants

Nov 28, 2024

NEW YORK,Nov. 27,2024--As winter settles in,it\'s the perfect time to reflect on the warmth and comfort that help us through the colder months. This season of gratitude,baleaf proudly celebrates a dec

The trading volume of green electricity in Turfan, Xinjiang exceeded 50 million kilowatt-hours

Nov 28, 2024

TURFAN,China,Nov. 28,2024-- As of November 24,the trading power of green power in Turfan,Xinjiang this year has reached 50.3205 million kilowatt-hours,successfully breaking through the 50 million kilo

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease

Nov 26, 2024

HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported and such findings were proportional between pl

1 ... 195 196 197 198 199 200 201 ... 350